Europe Influenza Vaccines Market to be Worth around USD 650 Mln by 2021, Expects iGATE Research in New Report Available at MarketPublishers.com12 Dec 2016 • by Natalie Aster
LONDON – Globally, influenza viruses are the number one cause of morbidity and mortality. There is a vast population base in the global marketplace, but vaccination coverage is still low in emerging markets. With government support rising across the globe, this marketplace is set to post continuous growth in the offing.
The European market for influenza vaccines is projected to be worth around USD 650 million by 2021.
Transformation taking place in the vaccines technologies space is one of these factors. Breakthroughs in the field of technology and science are another driver. Growing awareness over seasonal influenza and vaccination also encourage growth in this market space.
The marketplace, however, has to cope with different challenges like regulatory barriers, general technical barriers, and more.
In Europe, Germany is the number one player - this country owns the largest share in this local marketplace. Italy, the U.K., France and Spain are also in the top five amongst European countries.
Fluzone and Fluvirin/Flucelvax are the two leading players when it comes to influenza vaccines brand sales.
New research report “Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021” drawn up by iGATE Research Pvt. Ltd. offers a very close look at the European market for influenza vaccines. The study starts with an all-round overview of the marketplace and gives projections of its development, thus covering the period 2011-2021.
It sheds light on performance of this market across such countries as Germany, France, the Netherlands, Sweden, and many more. The report explores sales of influenza vaccine brands and projects their trends through 2021. The research study proceeds with a discussion of the competitive environment.
It covers major deals and scrutinizes driving factors. The research report also throws light on challenges of the European market space.
More new studies by our partner can be found at iGATE Research page.